Last update:

Oncology & Cancer news

Oncology & Cancer

Study shows cancer vaccine blocks tumor progression at early lesion stage

A cancer vaccine that had little success in clinical trials for patients with advanced tumors could potentially have efficacy if administered earlier in the treatment cycle, according to a study from Vanderbilt researchers.

Oncology & Cancer

Harnessing natural killer T cells to advance cancer immunotherapy for solid tumors

In the fight against cancer, chimeric antigen receptor T cell (CAR-T) therapy has achieved notable success in treating blood cancers. However, it has been largely ineffective against solid tumors.

Oncology & Cancer

Study explores novel therapeutic treatment for glioblastoma

Glioblastoma (GBM) is the most lethal brain tumor, with a median survival rate of merely 12-16 months after diagnosis. Despite surgical, radiation and chemotherapy treatments, the two-year survival rate for GBM patients is ...

Oncology & Cancer

Study unveils the role of gamma-delta T cells in cancer immunology

A new study published in Cell Reports Medicine reveals critical insights into the role of gamma-delta T cells across 33 cancer types, shedding light on their potential as clinical biomarkers and therapeutic targets in cancer ...

Oncology & Cancer

Colonoscopies among the young are on the rise

Colon cancers are increasing among younger Americans, so much so that experts advised in 2021 that colonoscopy screening begins at the age of 45, not 50 as had been previously recommended.

Oncology & Cancer

Video: Breaking through radiation therapy myths

People who have cancer might have the disease treated with several therapies, including chemotherapy and radiation. Radiation therapy, which more than half of all people with cancer receive as part of their treatment, uses ...